Integral Health Asset Management, LLC
Position in RVMD — Revolution Medicines, Inc.
CIK 1773206
New York, NY
Position in RVMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$145,875,000
+$50,295,000 QoQ
Shares Held
1,500,000
+25.0% QoQ
Ownership
0.706%
of shares outstanding
% of Portfolio
7.72%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Derivatives in RVMD
reported options exposure · as of Mar 31, 2026CallValue
$48,625,000
CallShares
500,000
PutValue
$72,937,500
PutShares
750,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Integral Health Asset Management, LLC holds $1,255,592,830 across 56 Biotechnology names. RVMD ranks #2 (11.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
1,500,000 | $245,280,000 | |
| 2 | RVMD |
Revolution Medicines, Inc.
This page
|
1,500,000 | $145,875,000 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,600,000 | $105,456,000 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
85,000 | $65,674,400 | |
| 5 | VERA |
Vera Therapeutics, Inc.
|
1,600,000 | $64,368,000 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
2,000,000 | $55,400,000 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
600,000 | $52,182,000 | |
| 8 | EWTX |
Edgewise Therapeutics, Inc.
|
1,600,000 | $50,400,000 |
All Filings in RVMD
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $48,625,000 | 500,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $72,937,500 | 750,000 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $145,875,000 | 1,500,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $95,580,000 | 1,200,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $18,680,000 | 400,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,956,750 | 325,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,840,000 | 250,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $24,057,000 | 550,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $15,872,500 | 350,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $12,613,250 | 325,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $13,536,600 | 420,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,736,000 | 200,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $14,532,000 | 525,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,523,000 | 356,000 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,472,700 | 345,000 | Shares | Sole | 2023-05-09 | |
| No filing history on record for this holder in this stock. | ||||||